Announcement
08 Jan 2021
In January 2021, the Norwegian authorities introduced an export notification on certain types of tocilizumab following the outbreak of COVID-19.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
08 Jan 2021
Revocation date:
09 Apr 2021
Removed: 31 May 2021
Export licensing requirement
On 8 January 2021, the Norwegian Medicines Agency introduced an export notification on tocilizumab. The notification requirement was introduced as the products were considered to be at risk of shortag...
Sign in to see more
Threads
See all
Harmful Trade Policy Measures
This Thread tracks harmful trade policy interventions affecting all products. Covering all types of interventions monitored by Global Trade Alert, it highlights how the yearly number of these measures has evolved over time.
Published: 04 Sep 2024
70908
interventions
194
jurisdictions
Harmful Trade Policy Interventions: Medical Goods
This Thread tracks harmful trade policy interventions affecting HS codes for medical consumables, equipment, medicines, vaccines, as well as chemicals used in pharmaceutical production. It covers all types of interventions monitored by Global Trade Alert since 2009. To identify relevant policy actions, the Global Trade Alert team focused on the identification of relevant HS codes following the pr...
Published: 09 Jan 2025
7375
interventions
152
jurisdictions
Export Restrictions: Medical Goods
This Thread tracks export restrictions affecting HS codes for medical consumables, equipment, medicines, vaccines, as well as chemicals used in pharmaceutical production. It covers policy actions monitored by Global Trade Alert since 2009. To identify relevant policy actions, the Global Trade Alert team focused on the identification of relevant intervention types and HS codes. For intervention ty...
Published: 09 Jan 2025
658
interventions
98
jurisdictions